Research - London, England, United Kingdom
VASGEN LIMITED is an early-stage biotech company based in London UK developing novel monoclonal antibody therapeutics for unmet clinical needs in ophthalmology and cancer medicine. The company is developing a breakthrough antibody platform (AbIMP®) that generates selective inhibitors of therapeutically important but previously intractable metzincin protease targets.
Apache
123-reg DNS
WordPress.org